Philippe Krolicki's Email & Phone Number
Chronic Pain indication Team Lead, Tanezumab (biologic – phase III asset) @ Pfizer Inc.
Philippe Krolicki Email Addresses
Philippe Krolicki's Work Experience
Pfizer Inc.
Chronic Pain indication Team Lead, Tanezumab (biologic – phase III asset)
January 2009 to April 2010
Marketing Director, Asenapine Global Asset Team (phase III asset - co-promote w/ Organon)
February 2004 to December 2006
Pfizer France
Senior Product manager
February 1999 to September 2002
Pfizer France
Product Manger
February 1997 to February 1999
Pfizer France
Medical representative
August 1996 to February 1997
Servier - Germany
Hospital representative
January 1995 to May 1996
p-valorem
Founder CEO
Show more
Show less
Frequently Asked Questions about Philippe Krolicki
What is Philippe Krolicki email address?
Email Philippe Krolicki at [email protected] and [email protected]. This email is the most updated Philippe Krolicki's email found in 2024.
How to contact Philippe Krolicki?
To contact Philippe Krolicki send an email to [email protected] or [email protected].
What company does Philippe Krolicki work for?
Philippe Krolicki works for Pfizer Inc.
What is Philippe Krolicki's role at Pfizer Inc.?
Philippe Krolicki is Chronic Pain indication Team Lead, Tanezumab (biologic – phase III asset)
What is Philippe Krolicki's Phone Number?
Philippe Krolicki's phone (212) ***-*117
What industry does Philippe Krolicki work in?
Philippe Krolicki works in the Pharmaceuticals industry.
Philippe Krolicki's Professional Skills Radar Chart
Based on our findings, Philippe Krolicki is ...
What's on Philippe Krolicki's mind?
Based on our findings, Philippe Krolicki is ...
Philippe Krolicki's Estimated Salary Range
Philippe Krolicki Email Addresses
Find emails and phone numbers for 300M professionals.
Search by name, job titles, seniority, skills, location, company name, industry, company size, revenue, and other 20+ data points to reach the right people you need. Get triple-verified contact details in one-click.In a nutshell
Philippe Krolicki's Ranking
Ranked #426 out of 8,512 for Chronic Pain indication Team Lead, Tanezumab (biologic – phase III asset) in New York
Philippe Krolicki's Personality Type
Extraversion (E), Sensing (S), Feeling (F), Judging (J)
Average Tenure
2 year(s), 0 month(s)
Philippe Krolicki's Willingness to Change Jobs
Unlikely
Likely
Open to opportunity?
There's 88% chance that Philippe Krolicki is seeking for new opportunities
Philippe Krolicki's Social Media Links
/in/philippe-krolicki-b490511 /company/optichronix /school/universit%c3%a9-de-paris/